High iron levels in females most commonly result from menopause, genetic conditions, or underlying diseases that disrupt the body’s ability to regulate iron. Before menopause, monthly blood loss through menstruation keeps iron stores relatively low, with average ferritin levels around 70 ng/mL. After menopause, ferritin levels rise two- to threefold, averaging around 129 ng/mL, because iron that was once lost each month now accumulates in the body.
Understanding the cause matters because untreated iron overload can damage the liver, heart, and pancreas over time. A transferrin saturation above 50% on a blood test generally signals iron overload and warrants further investigation.
Menopause and Rising Iron Stores
The single biggest reason iron levels climb in women is the transition through menopause. As menstrual periods become irregular during perimenopause and eventually stop, the body loses its primary route for shedding iron. This period of fluctuation can last up to 10 years, and iron accumulates steadily throughout. Body iron storage roughly doubles from about 4.8 mg per kilogram of body weight at the start of perimenopause (around age 45) to about 12 mg per kilogram by age 60.
Estrogen drops by about 90% during this transition, and iron rises in an almost mirror-image pattern. Before menopause, nearly 79% of women have ferritin levels below 100 ng/mL. After menopause, that figure drops to about 56%, meaning nearly half of postmenopausal women have ferritin above 100. This shift is entirely normal and expected, but it means postmenopausal women face iron-related health risks that premenopausal women rarely encounter.
Hereditary Hemochromatosis
The most common genetic cause of iron overload is hereditary hemochromatosis, a condition where the body absorbs too much iron from food. It’s caused by mutations in the HFE gene, particularly two variants known as C282Y and H63D. About 0.16% of women in the United States carry two copies of the C282Y mutation, the combination most likely to cause significant iron buildup. Roughly 2% carry a mixed pair (one C282Y and one H63D), and about 2% carry two copies of H63D, both of which carry a lower but real risk.
Women with hemochromatosis often develop symptoms later than men because menstruation delays iron accumulation for decades. Many women don’t notice problems until after menopause, when iron stores begin climbing without that monthly offset. Symptoms develop gradually and can include persistent fatigue, joint pain (especially in the knees and hands), abdominal pain over the liver area, loss of interest in sex, and a darkening of the skin that may look gray, metallic, or bronze.
Left untreated, the excess iron deposits in organs. Cirrhosis develops in about 70% of people with unmanaged hemochromatosis, and their risk of liver cancer is 20 times higher than the general population. Iron in the pancreas causes diabetes in roughly half of people who carry two copies of the main mutation. The heart can also be affected, leading to heart failure or irregular rhythms. With severe organ damage already present at diagnosis, life expectancy can drop to less than two years, which is why early detection matters so much.
Blood Transfusions and Blood Disorders
Women who receive frequent blood transfusions for chronic conditions are at high risk for secondary iron overload. Each unit of transfused red blood cells delivers 200 to 250 mg of iron, and the body has no efficient way to get rid of it. Over months or years of regular transfusions, iron accumulates in the liver, heart, and other organs.
The conditions that most commonly lead to transfusion-related iron overload include transfusion-dependent thalassemia, myelodysplastic syndrome, sickle cell disease, aplastic anemia, and chronic kidney disease requiring transfusions. Some of these conditions also cause iron overload through a second mechanism: ineffective red blood cell production in the bone marrow signals the gut to absorb even more iron from food, compounding the problem from transfusions.
Liver Disease and Inflammation
The liver is the control center for iron regulation. It produces a hormone called hepcidin that acts like a gatekeeper, controlling how much iron enters the bloodstream from the gut and from storage sites. When the liver is damaged by chronic disease, hepcidin production drops, and the body loses its ability to keep iron in check.
Chronic liver conditions, including fatty liver disease, hepatitis, and alcohol-related liver damage, can all lead to lower hepcidin levels and a gradual rise in iron. Interestingly, acute liver injury has the opposite effect, temporarily raising hepcidin and lowering blood iron. It’s the slow, chronic damage that creates the conditions for iron to build up over time. This means women with ongoing liver problems may show elevated iron on blood tests even without a genetic predisposition.
Inflammation from other chronic conditions can also raise ferritin levels on blood tests, though this sometimes reflects the body’s inflammatory response rather than true iron overload. Ferritin is what’s called an acute-phase reactant: it rises during infections, autoimmune flares, and other inflammatory states. This is why doctors typically check transferrin saturation alongside ferritin to distinguish between inflammation and genuine excess iron.
Iron Supplements and Diet
The upper tolerable daily intake of iron for adults is 45 mg from all sources combined, including food, drinks, and supplements. Women who continue taking iron supplements after their iron deficiency has resolved, or who take high-dose supplements without monitoring, can push their iron stores above healthy levels. This is especially relevant after menopause, when the body is already retaining more iron naturally.
Diet alone is unlikely to cause clinical iron overload in someone with normal iron metabolism. High red meat consumption has been linked to elevated ferritin levels, but in healthy individuals the body’s regulatory system adjusts absorption to prevent dangerous buildup. The risk from diet becomes meaningful mainly when it’s layered on top of another cause, like a genetic mutation or chronic liver disease, that has already compromised the body’s iron regulation.
How High Iron Is Detected
Iron overload often goes unrecognized for years because its early symptoms, particularly fatigue and joint stiffness, overlap with so many other conditions and with normal aging. Two blood tests form the core of diagnosis. Serum ferritin reflects how much iron is stored in your body. Transferrin saturation measures the percentage of your blood’s iron-carrying protein that is currently loaded with iron: below 20% suggests deficiency, while above 50% suggests overload.
If both tests come back high, genetic testing for HFE mutations is typically the next step. When genetic testing is negative but iron markers remain elevated, doctors look for secondary causes like liver disease, blood disorders, or excess supplementation. In some cases, imaging of the liver can measure iron concentration directly without a biopsy.
For women specifically, the timing of testing matters. A ferritin of 120 ng/mL in a 55-year-old woman who recently went through menopause may be a normal postmenopausal shift. The same value in a 30-year-old premenopausal woman would be unusual and worth investigating further. Context, including age, menstrual status, supplement use, and family history, shapes what any single number means.